Columbia University DKV | New York Academy of Sciences | Mailman School of Public Health | NIAID
Home Feedback | About | print Print | Help
Search
Speakers
Latest Headlines
Executive Summary
Topics and Speakers
Coronavirus Biology and Pathogenesis
On the Front Lines
Approaches to Vaccines and Drug Development
Future Perspectives on Emerging Infections
References and Resources
pdf Conference Transcript
pdf Conference Highlights
SARS in the Context of Emerging Infectious Threats SARS in the Context of Emerging Infectious Threats
Topics and Speakers

Research Report
SARS Aetiology: A Research Update from Malik Peiris

Welcome
Ellis Rubinstein, Chief Executive Officer, New York Academy of Sciences

Introductory Remarks
W. Ian Lipkin, Director of the Center for Immunopathogenesis and Infectious Diseases, Mailman School of Public Health, Columbia University, New York


Session I: Coronavirus Biology and Pathogenesis
Moderated by Scott Hammer

Speakers
Paul Masters, Wadsworth Center, NY State Dept. of Health, Albany
Molecular Biology of Coronaviruses

Kathryn V. Holmes, Department of Microbiology, University of Colorado Health Sciences Center, Denver
Coronavirus Pathogenesis

Linda Saif, Professor, Food Animal Health Research Program, Ohio State University, Wooster
Coronavirus Transmission and Persistence

Thomas Ksiazek, Centers for Disease Control and Prevention, Atlanta
Technology in SARS Discovery

Panel 1 Discussion


Session II: On the Front Lines
Moderated by Scott Hammer

Speakers
Larry Anderson, Centers for Disease Control and Prevention, Atlanta.
Clinical Spectrum of SARS Infection

Donald Low, Mt. Sinai Hospital, Toronto
Clinical Experience in Toronto

Chen Zhu, Shanghai Second Medical University, People's Republic of China. Delivered by Dr. Scott Hammer
SARS: An Update from China

Panel 2 Discussion


Session III: Approaches to Vaccines and Drug Development
Moderated by Scott Hammer

Speakers
David Ho, Aaron Diamond AIDS Research Center, New York
Blocking SARS Virus Fusion

Frederick Hayden, University of Virginia School of Medicine, Charlottesville
Lessons in Interventions for SARS

Catherine Laughlin, National Institute of Allergy and Infectious Diseases, Bethesda
Status of Drug Screening vs. SARS

C. Richter King, GenVec Inc., Gaithersburg, VA
Adenovirus Vector Technologies for Vaccines

Thomas Monath, Acambis, Cambridge, MA
Some Approaches to Vaccine Development

Panel 3 Discussion with Richard Colonno (Bristol-Myers Squibb), Michael Dunne (Pfizer) and Emilio Emini (Merck)


Session IV: Future Perspectives on Emerging Infections
Moderated by Allan Rosenfield

Speakers
C.J. Peters, University of Texas Medical Branch, Galveston
Special Pathogens in Three Cultures

Marcelle Layton, NY City Department of Health
SARS and Public Health Systems

John La Montagne, National Institute of Allergy and Infectious Diseases, Bethesda
A View from the Field and the Bridge

Panel 4 Discussion


Columbia University Digital Knowledge Ventures New York Academy of Sciences Columbia University Mailman School of Public Health National Institute of Allergy and Infectious Diseases United States Department of Health & Human Services
© 2003 Columbia University | Privacy Policy.
This Web site is being provided to you for your own use.
Any copying or distribution of this Web site is prohibited.